Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Universal Corp
NYSE:UVV
|
US |
Bellevue Life Sciences Acquisition Corp
Total Equity
Bellevue Life Sciences Acquisition Corp
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bellevue Life Sciences Acquisition Corp
NASDAQ:BLAC
|
Total Equity
$32.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WP Carey Inc
NYSE:WPC
|
Total Equity
$8.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
AltC Acquisition Corp
NYSE:OKLO
|
Total Equity
$1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Annaly Capital Management Inc
NYSE:NLY
|
Total Equity
$16.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
|
Ares Capital Corp
NASDAQ:ARCC
|
Total Equity
$14.3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
|
SoFi Technologies Inc
NASDAQ:SOFI
|
Total Equity
$10.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bellevue Life Sciences Acquisition Corp
Glance View
Bellevue Life Sciences Acquisition Corp. operates as a blank check company. The company is headquartered in Bellevue, Washington. The company went IPO on 2023-02-10. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The firm has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm may pursue an acquisition opportunity in any business industry or sector. The firm intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The firm neither engaged in any operations nor generated any revenues.
See Also
What is Bellevue Life Sciences Acquisition Corp's Total Equity?
Total Equity
32.5m
USD
Based on the financial report for Dec 31, 2023, Bellevue Life Sciences Acquisition Corp's Total Equity amounts to 32.5m USD.
